Medical Device Sterilization and Sterile-Barrier Packaging

Independent · source-linked · manufacturing-first

Sterilization is not a final switch that makes any packaged part ready for use. Method, material, device geometry, residues, package system, dose or cycle and shelf-life evidence have to be developed together.

Select a compatible method

FDA describes several sterilization approaches and points manufacturers to recognized consensus standards. Method selection depends on the device, materials, packaging and intended claim; one method can damage a product that another can process effectively.

Packaging is part of the system

The sterile barrier must permit the selected process and maintain integrity through handling, distribution and labeled shelf life. Seal process, material lot, inspection and aging evidence should be controlled rather than treated as generic packaging activity.

Keep the claims precise

FDA guidance addresses sterility information for premarket submissions and labeling. A device or kit should not imply that everything is sterile if only a defined portion is. Labeling, device identity and packaging revision must remain synchronized.

A public Arthrex example

Arthrex announced salable production at its South Carolina X-ray sterilization facility and stated that the site was designed to support X-ray and electron-beam technology. That is a public example of vertical integration; it does not mean every Arthrex product follows the same method.

Continue the medical manufacturing map

Independent educational reference: Machine Blue Book is not affiliated with Arthrex, FDA, ISO or any manufacturer named on this page. Names are used descriptively and linked to primary sources. This material is not medical, legal, regulatory or clinical advice and does not recommend a device for patient care.